Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018

IMPORTANCE: Despite federal initiatives encouraging the enrollment of individuals from racial and ethnic minority groups in US clinical trials, no studies to date have specifically examined demographic disparities among participants in phase 1 drug development trials for patients with metastatic can...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunlop, Hayley, Fitzpatrick, Evelyn, Kurti, Kevin, Deeb, Stephanie, Gillespie, Erin F., Dover, Laura, Yerramilli, Divya, Gomez, Scarlett Lin, Chino, Fumiko, Tsai, C. Jillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634497/
https://www.ncbi.nlm.nih.gov/pubmed/36326764
http://dx.doi.org/10.1001/jamanetworkopen.2022.39884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634497/
https://www.ncbi.nlm.nih.gov/pubmed/36326764
http://dx.doi.org/10.1001/jamanetworkopen.2022.39884

Ejemplares similares